Need for adjuvant radiotherapy in oral cancer: depth of invasion rather than tumor diameter.

Autor: Riemenschnitter CE; Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland. Cosima.Riemenschnitter@usz.ch., Morand GB; Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland., Schouten CS; Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland., Rupp NJ; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Balermpas P; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland., Gander T; Department of Cranio-Maxillo-Facial and Oral Surgery, University Hospital Zurich, Zurich, Switzerland., Broglie Däppen MA; Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Zurich, Frauenklinikstrasse 24, 8091, Zurich, Switzerland.

Publikováno v: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2023 Jan; Vol. 280 (1), pp. 339-346. Date of Electronic Publication: 2022 Aug 01.

Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.

Autor: Schouten CS; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands., Hakim S; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands., Boellaard R; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands., Bloemena E; Department of Oral and Maxillofacial Surgery/Oral Pathology, VU University Medical Center/Academic Center for Dentistry Amsterdam (ACTA), Amsterdam, The Netherlands.; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Doornaert PA; Department of Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands., Witte BI; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands., Braakhuis BJ; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands., Brakenhoff RH; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands., Leemans CR; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands., Hoekstra OS; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, The Netherlands., de Bree R; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands.

Publikováno v: Head & neck [Head Neck] 2016 Apr; Vol. 38 (4), pp. 529-35. Date of Electronic Publication: 2015 May 26.

Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.

Autor: Schouten CS; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., de Graaf P; Department of Radiology and Nuclear Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Alberts FM; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Hoekstra OS; Department of Radiology and Nuclear Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Comans EF; Department of Radiology and Nuclear Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Bloemena E; Department of Oral and Maxillofacial Surgery/Oral Pathology, VU University Medical Center/Academic Center for Dentistry (ACTA), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands; Department of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Witte BI; Department of Epidemiology and Biostatistics, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Sanchez E; Department of Radiology and Nuclear Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Leemans CR; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., Castelijns JA; Department of Radiology and Nuclear Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands., de Bree R; Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands; Department of Head and Neck Surgery, UMC Utrecht Cancer Center, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Electronic address: r.debree@vumc.nl.

Publikováno v: Oral oncology [Oral Oncol] 2015 May; Vol. 51 (5), pp. 541-7. Date of Electronic Publication: 2015 Feb 26.

Diffusion-weighted EPI- and HASTE-MRI and 18F-FDG-PET-CT early during chemoradiotherapy in advanced head and neck cancer.

Autor: Schouten CS; 1 Department of Otolaryngology-Head and Neck Surgery, 2 Department of Radiology and Nuclear Medicine, 3 Department of Epidemiology and Biostatistics, 4 Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands., de Bree R; 1 Department of Otolaryngology-Head and Neck Surgery, 2 Department of Radiology and Nuclear Medicine, 3 Department of Epidemiology and Biostatistics, 4 Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands., van der Putten L; 1 Department of Otolaryngology-Head and Neck Surgery, 2 Department of Radiology and Nuclear Medicine, 3 Department of Epidemiology and Biostatistics, 4 Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands., Noij DP; 1 Department of Otolaryngology-Head and Neck Surgery, 2 Department of Radiology and Nuclear Medicine, 3 Department of Epidemiology and Biostatistics, 4 Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands., Hoekstra OS; 1 Department of Otolaryngology-Head and Neck Surgery, 2 Department of Radiology and Nuclear Medicine, 3 Department of Epidemiology and Biostatistics, 4 Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands., Comans EF; 1 Department of Otolaryngology-Head and Neck Surgery, 2 Department of Radiology and Nuclear Medicine, 3 Department of Epidemiology and Biostatistics, 4 Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands., Witte BI; 1 Department of Otolaryngology-Head and Neck Surgery, 2 Department of Radiology and Nuclear Medicine, 3 Department of Epidemiology and Biostatistics, 4 Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands., Doornaert PA; 1 Department of Otolaryngology-Head and Neck Surgery, 2 Department of Radiology and Nuclear Medicine, 3 Department of Epidemiology and Biostatistics, 4 Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands., Leemans CR; 1 Department of Otolaryngology-Head and Neck Surgery, 2 Department of Radiology and Nuclear Medicine, 3 Department of Epidemiology and Biostatistics, 4 Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands., Castelijns JA; 1 Department of Otolaryngology-Head and Neck Surgery, 2 Department of Radiology and Nuclear Medicine, 3 Department of Epidemiology and Biostatistics, 4 Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands.

Publikováno v: Quantitative imaging in medicine and surgery [Quant Imaging Med Surg] 2014 Aug; Vol. 4 (4), pp. 239-50.